Boston, MA -- (SBWIRE) -- 09/11/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Spirit Realty Capital Inc (NYSE:SRC), VIVUS, Inc.(NASDAQ:VVUS), Triangle Petroleum Corporation (NYSEAMEX:TPLM), MannKind Corporation(NASDAQ:MNKD)
Spirit Realty Capital Inc (NYSE:SRC) shares dropped 0.44% to $9.11. The company on Sept. 5 announced that its Board of Directors has declared a $0.001783 per share daily cash dividend for the period from July 17, 2013, the effective date of Spirit Realty Capital's merger with Cole Credit Property Trust II, Inc. ("Cole II"), through September 30, 2013. This dividend equates to an annualized rate of $0.65625 per share.
Is SRC A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
VIVUS, Inc.(NASDAQ:VVUS) shares declined 4.21% to $10.46. The company on Sept. 4 said new Chief Executive Officer Tony Zook has resigned because of health reasons. Seth H. Z. Fischer, formerly with Johnson & Johnson (JNJ), will replace Zook immediately, the Mountain View, California-based company said in a statement.
Additionally, the company on August 6 reported its financial results for the quarter ended June 30, 2013. Net product revenue from sales of Qsymia in the first half of 2013 was $9.6 million. For the six months ended June 30, 2013, we reported a net loss of $109.1 million, or $1.08 net loss per share, as compared to a net loss of $42.8 million, or $0.45 net loss per share during the first half of 2012.
Is VVUS A Good Buy After The Recent Price Movement? Find Out Here
Triangle Petroleum Corporation (NYSEAMEX:TPLM) shares jumped 17.15% to $8.88. The company on Sept. 9 provides an operational update and reports its second quarter fiscal 2014 results for the three-month period ended July 31, 2013 ("Q2 fiscal 2014"). Increased quarterly sales volumes to 394 Mboe (+277% y/y, 4,287 Boepd) as compared to 105 Mboe (1,138 Boepd) in the same period in Q2 fiscal 2013.
How Should Investors Trade TPLM After The Recent Volatility? Get Free Report Here
MannKind Corporation(NASDAQ:MNKD) shares jumped 1.17% to $6.05. The company on August 14 reported positive preliminary results from Study 171, a Phase 3 clinical study of AFREZZA Inhalation Powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation (Gen2) inhaler (also known as the Dreamboat™ inhaler), in patients with type 1 diabetes.
Additionally, the company was scheduled to present at Morgan Stanley Global Healthcare Conference on September 10, 2013 at 3:30 PM (ET) at the Grand Hyatt Hotel in New York City.
How Should Investors Trade MNKD After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)